The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Share News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: UBS Initiates Restaurant Group At Buy

Fri, 18th Dec 2015 09:39

LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
Societe Generale Cuts Glencore Price Target To 100p From 130p, Keeps Buy
----------
EXANE BNP CUTS MARKS & SPENCER PRICE TARGET TO 580 (620) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES DIXONS CARPHONE PRICE TARGET TO 560 (510) PENCE - 'OUTPERFORM'
----------
UBS CUTS RIO TINTO PRICE TARGET TO 2600 (2700) PENCE - 'BUY'
----------
UBS CUTS ANTOFAGASTA PRICE TARGET TO 450 (510) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS RIO TINTO PRICE TARGET TO 1700 (1825) PENCE - 'SELL'
----------
GOLDMAN CUTS BHP BILLITON PRICE TARGET TO 750 (925) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ANGLO AMERICAN PRICE TARGET TO 250 (280) PENCE - 'SELL'
----------
FTSE 250
----------
UBS INITIATES RESTAURANT GROUP WITH 'BUY' - TARGET 860 PENCE
----------
Numis Cuts Elementis Target To 253p From 271p, Keeps Add
----------
EXANE BNP CUTS ELEMENTIS PRICE TARGET TO 220 (250) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS ELEMENTIS PRICE TARGET TO 215 (255) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS N BROWN PRICE TARGET TO 260 (280) PENCE - 'UNDERPERFORM'
----------
EXANE BNP CUTS HOME RETAIL PRICE TARGET TO 80 (100) PENCE - 'UNDERPERFORM'
----------
N+1 Singer Upgrades Bodycote To Buy From Hold, Price Target At 635p
----------
UBS CUTS VEDANTA PRICE TARGET TO 330 (400) PENCE - 'NEUTRAL'
----------
UBS CUTS ACACIA MINING PRICE TARGET TO 275 (300) PENCE - 'BUY'
----------
UBS CUTS BOVIS HOMES PRICE TARGET TO 1290 (1450) PENCE - 'BUY'
----------
BARCLAYS CUTS VICTREX TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 2100 (2300) PENCE
----------
BERENBERG RAISES NORTHGATE TO 'HOLD' ('SELL') - TARGET 400 (455) PENCE
----------
MAIN MARKET AND AIM
----------
Liberum Cuts PureTech Health Target To 194p From 199p, Keeps Buy
----------
Cantor Fitzgerald Cuts Bonmarche Holdings Target To 230p From 350p
----------
Cantor Fitzgerald Downgrades Bonmarche Holdings To Hold From Buy
----------
Panmure Ups Midatech Pharma Target To 476p From 417p, Keeps Buy
----------
PANMURE CUTS FENNER PRICE TARGET TO 100 (125) PENCE - 'SELL'
----------
EXANE BNP CUTS SIGNET GROUP PRICE TARGET TO 9400 (10000) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES ASOS PRICE TARGET TO 4400 (4100) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS IMAGINATION TECHNOLOGIES PRICE TARGET TO 95 (130) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK CUTS IMAGINATION TECHNOLOGIES PRICE TARGET TO 105 (215) PENCE - 'HOLD'
----------
HSBC CUTS STHREE PRICE TARGET TO 405 (425) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
29 Jan 2019 16:56

Midatech Pharma To Raise GBP8 Million, Enters Licence Deal (ALLISS)

LONDON (Alliance News) - Midatech Pharma PLC on Tuesday said it entered into conditional agreements to raise GBP8 million by way of a subscription for new ordinary shares at 3.85 pence per on of a

Read more
25 Jan 2019 17:18

LONDON MARKET CLOSE: Stocks Mixed As Miners Rise But Vodafone Sinks

LONDON (Alliance News) - Stocks in London finished the week mixed as commodity miners were unable to keep the FTSE 100 in the green with Vodafone dragging the index lower.The FTSE 100 closed down

Read more
25 Jan 2019 10:40

WINNERS & LOSERS SUMMARY: Earthport Gains As Mastercard Out Bids Visa

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 3.2%. UBS raised the Mexican miner to Buy

Read more
25 Jan 2019 09:51

Midatech Pharma Shares Halve Amid Urgent Scramble To Secure Cash

LONDON (Alliance News) - Shares in Midatech Pharma PLC more than halved Friday as it said it is urgently looking to conclude a deal with a strategic investor with cash funds rapidly running the it

Read more
25 Jan 2019 08:35

Midatech seeking cash after FDA feedback

(Sharecast News) - Oncology and rare disease-focussed company Midatech Pharma announced on Friday that it has received feedback from the US Food and Drug Administration (FDA) on the regulatory study for its lead product, 'MTD201 Q-Octreotide'.

Read more
20 Dec 2018 10:12

Midatech inks evaluation agreement with Asian pharma outfit

(Sharecast News) - Pharmaceutical research and development outfit Midatech has inked an agreement with an unnamed company to evaluate its Q-Sphera drug delivery platform.

Read more
1 Nov 2018 11:37

Midatech Pharma Completes Sale Of US Business To Kanwa Holdings

LONDON (Alliance News) - Immunotherapy-focused pharmaceutical company Midatech Pharma PLC said on Thursday it has completed sale of Midatech Pharma US Inc to Kanwa Holdings LP, owned by Baring for

Read more
8 Oct 2018 15:59

UK Shareholder Meetings Calendar - Next 7 Days

Tuesday 9 Octoberno events scheduledWednesday 10 October Whitbread (sale of Costa

Read more
27 Sep 2018 10:44

Midatech Narrows Loss, Agrees Sale Of US Unit For Up To USD19 million

LONDON (Alliance News) - Midatech Pharma PLC reported a narrowed interim loss as it planned to divest its US unit to become a "pure play biotech company".Total revenue for the six

Read more
31 Aug 2018 10:36

WINNERS & LOSERS SUMMARY: Whitbread Surges On Costa Coffee Sale

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 16%. The hospitality firm said it agreed the

Read more
31 Aug 2018 09:38

Midatech Pharma Shares Rise Following Positive MTD201 Trial Data

LONDON (Alliance News) - Shares in Midatech Pharma PLC jumped on Friday following positive data from its proof of concept exploratory study for its key oncology drug candidate MTD201.Shares

Read more
25 Jul 2018 12:26

Midatech Expects 16% Half-Year Revenue Increase Amid Confident Outlook

LONDON (Alliance News) - Midatech Pharma PLC said Wednesday it expects to meet market expectations for 2018 after increasing half-year revenue year-on-year.For the six months to June 30, it

Read more
25 Jul 2018 10:15

Midatech Pharma 'on track' for first half

(Sharecast News) - Cancer-focused pharmaceutical company Midatech Pharma has remained "on track" to deliver financial results for the first half of the calendar year in line with market expectations, and was still exploring options about how to meet its cash flow needs.

Read more
25 May 2018 12:23

Midatech Pharma Commences First In-Human Study Of Brain Cancer Drug

LONDON (Alliance News) - Midatech Pharma PLC said Friday it started the first in-human study of childhood brain cancer drug MTX110.The study will be a combined phase 1 and phase 2 clinical

Read more
3 May 2018 12:14

MidaTech Pharma "Not Aware Of Any Reason" For Sharp Share Price Drop

LONDON (Alliance News) - Midatech Pharma PLC said Thursday that it is "not aware of any reason" behind the sharp drop in its share price.Midatech shares were down 22% at 35.80 its

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.